- Home
- ISRL vs ACTU Comparison
ISRL vs ACTU Comparison
Compare ISRL & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRL
- ACTU
- Stock Information
- Founded
- ISRL 2021
- ACTU 2015
- Country
- ISRL United States
- ACTU United States
- Employees
- ISRL N/A
- ACTU N/A
- Industry
- ISRL Blank Checks
- ACTU
- Sector
- ISRL Finance
- ACTU
- Exchange
- ISRL Nasdaq
- ACTU NYSE
- Market Cap
- ISRL 145.6M
- ACTU 162.1M
- IPO Year
- ISRL 2023
- ACTU 2024
- Fundamental
- Price
- ISRL $11.36
- ACTU $8.62
- Analyst Decision
- ISRL
- ACTU
- Analyst Count
- ISRL 0
- ACTU 0
- Target Price
- ISRL N/A
- ACTU N/A
- AVG Volume (30 Days)
- ISRL 35.6K
- ACTU 50.4K
- Earning Date
- ISRL 01-01-0001
- ACTU 02-21-2025
- Dividend Yield
- ISRL N/A
- ACTU N/A
- EPS Growth
- ISRL N/A
- ACTU N/A
- EPS
- ISRL 0.26
- ACTU N/A
- Revenue
- ISRL N/A
- ACTU N/A
- Revenue This Year
- ISRL N/A
- ACTU N/A
- Revenue Next Year
- ISRL N/A
- ACTU N/A
- P/E Ratio
- ISRL $43.53
- ACTU N/A
- Revenue Growth
- ISRL N/A
- ACTU N/A
- 52 Week Low
- ISRL $10.69
- ACTU $5.51
- 52 Week High
- ISRL $11.50
- ACTU $10.16
- Technical
- Relative Strength Index (RSI)
- ISRL 51.41
- ACTU N/A
- Support Level
- ISRL $11.30
- ACTU N/A
- Resistance Level
- ISRL $11.50
- ACTU N/A
- Average True Range (ATR)
- ISRL 0.02
- ACTU 0.00
- MACD
- ISRL 0.00
- ACTU 0.00
- Stochastic Oscillator
- ISRL 30.00
- ACTU 0.00
About ISRL Israel Acquisitions Corp
Israel Acquisitions Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.